comparemela.com

Thomas Chalberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genascence to Present at Biotech Showcase 2024

/PRNewswire/ Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal.

Genascence to Present Full Data from Phase 1 Clinical Trial on GNSC-001, Company s Lead Program in Osteoarthritis, at European Society of Gene & Cell Therapy 30th Annual Congress

Genascence Names Ian Lachlan McLean, M D Ph D as Chief Medical Officer

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.